The history of the controversial relationship between mast cells and basophils

Immunology Letters

Volumn 141, Issue 1, 2011, Pages 10-17

  Crivellato, Enrico ^a   Nico, Beatrice ^b   Ribatti, Domenico ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Basophils; History; Mast cells

Indexed keywords

AUTOANTIBODY; BASOPHIL GROWTH FACTOR; CYTOKINE; GROWTH FACTOR; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 3; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ALLERGENICITY; ALLERGY; ANAPHYLAXIS; ANTIGEN PRESENTING CELL; BASOPHIL; BASOPHIL DEGRANULATION; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CELL DAMAGE; CELL GRANULE; CELL HETEROGENEITY; CELL HOMING; CELL INTERACTION; CELL ISOLATION; CELL POPULATION; CELL SPECIFICITY; CELL STRUCTURE; CELLULAR IMMUNITY; CHEMOTAXIS; CONCEPT FORMATION; CYTOLOGY; DISEASE ACTIVITY; DISEASE COURSE; GENETIC ENGINEERING; HUMAN; HUMORAL IMMUNITY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; LEUKOCYTE FUNCTION; LYMPHOCYTE DIFFERENTIATION; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVIEW; STEM CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANILINE COMPOUNDS; ANIMALS; ANTIGEN-PRESENTING CELLS; BASOPHILS; COLORING AGENTS; HEMATOLOGY; HEPARIN; HISTAMINE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MAST CELLS; MICE; PHYLOGENY; RATS;

EID: 80955144381     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.06.008     Document Type: Review

References (107)

1. Ehrlich P. Beiträge zur Theorie und Praxis der histologischen Färbung. Thesis, Leipzig University; 1878.
2. Crivellato E., Beltrami C.A., Mallardi F., Ribatti D. Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells. Br J Haematol 2003, 123:19-21.
3. Ehrlich P. Farbenanalytische Untersuchungen zur Histologie und Klinik des Blutes 1891, Berlin, Hirschwald.
4. Ehrlich P, Lazarus A. Die Anemie, 1. Normale und Patologische Histologie des Blutes. Wien: Holder; 1898 (revised and republished 1909).
5. Jolly M.J. Clasmatocytes et mastzellen. Comp Rend Soc Biol (Paris) 1900, 52:437-455.
6. Kanthack A.A., Hardy W.B. The morphology and distribution of the wandering cells of mammalian. J Physiol 1894, 17:81-119.
7. Hardy W.B., Wesbrook F.F. The wandering cells of the alimentary canal. J Physiol 1895, 18:490-524.
8. Enerbäck L. Mast cells in rat gastrointestinal mucosa. 1. Effects of fixation. Acta Pathol Microbiol Scand 1966, 66:289-302.
9. Enerbäck L. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. Acta Pathol Microbiol Scand 1966, 66:303-312.
10. Crivellato E., Ribatti D. The fundamental contribution of William Bate Hardy to shape the concept of mast cell heterogeneity. Br J Haematol 2010, 150:152-157.
11. Michels N.A. The mast cells. Handbook of hematology 1 1938, 232-354. Hoeber, New York. H. Downey (Ed.).
12. Holmgren H., Wilander O. Beitrag zur Kenntniss der Chemie und Funktion der Ehrlichschen Mastzellen. Z mikrosk-anat Forsch 1937, 42:242-278.
13. Jorpes E., Holmgren H., Wilander O. über das Vorkommen von Heparin in den Gefässwänden und in den Augen. Ein Beitrag zur Physiologie der Ehrlichschen Mastzellen. Z mikrosk-anat Forsch 1937, 42:279-301.
14. Rocha E., Silva M. Concerning the mechanism of anaphylaxis and allergy. Br Med J 1952, 779-784.
15. Riley J.F. Heparin, histamine and mast cells. Blood 1954, 9:1123-1126.
16. Riley J.F. Pharmacology and functions of mast cells. Pharmacol Rev 1955, 7:267-277.
17. Riley J.F., West G.B. The presence of histamine in tissue mast cells. J Physiol 1953, 120:528-537.
18. Riley J.F., West G.B. Skin histamine: its location in the tissue mast cells. Arch Dermatol 1956, 74:471-478.
19. Cass R., Riley J.F., West G.B., Head K.W., Stroud S.W. Heparin and histamine in mast cell tumours from dogs. Nature London 1954, 174:318.
20. Fawcett D.W. Cytological and pharmacological observations on the release of histamine by mast cells. J Exp Med 1954, 100:217-224.
21. Mota I., Vugman I. Effects of anaphylactic shock and compound 48/80 on the mast cells of the guinea pig lung. Nature 1956, 177:427-429.
22. Beaven M.A. Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol 2009, 39:11-25.
23. Graham H.T., Lowry O.H., Wheelwright F., Lenz M.A., Parish H.H. Distribution of histamine among leukocytes and platelets. Blood 1955, 10:467-481.
24. Behrens M., Taubert M. Proof of heparin in basophil leukocytes. Klin Wochensch 1952, 30:76-78.
25. Prausnitz C., Küstner H. Studien über die überempfindlichkeit. Ztrbl Bakt Paraskr Abt 1921, 86:160-169. 1.
26. Ishizaka K., Ishizaka T. Identification of γE-antibodies as a carrier of reaginic reactivity. J Immunol 1967, 99:1187-1198.
27. Ishizaka T., Ishizaka K., Orange R.P., Austen K.F. The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung. J Immunol 1970, 104:335-343.
28. Orange R.P., Austen W.G., Austen K.F. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophasphate. J Exp Med 1971, 134:136s-148s.
29. King M., Alaye N., Augustin R. Demonstration of reaginic antibodies on human basophils by immune adherence to allergen-coated Sepharose beads. Clin Allergy 1974, 6:339-348.
30. Blank U., Ra C., Miller L., White K., Metzger H., Kinet J.P. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 1989, 337:187-189.
31. Sutton B.J., Gould H.J. The human IgE network. Nature 1993, 366:421-428.
32. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M., et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005, 23:749-786.
33. Feldberg W., Kellaway D.H. Liberation of histamine and formation of lyscithin-like substances by cobra venom. J Physiol 1938, 94:187-226.
34. Brocklehurst W.E. The release of histamine and the formation of slow reacting substance (SRS-A) during anaphylactic shock. J Physiol 1960, 151:416-435.
35. Lewis R.A., Soter N.A., Diamond P.T., Austen K.F., Oates J.A., Roberts L.J. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982, 129:1627-1631.
36. Roberts L.J., Lewis R.A., Oates J.A., Austen K.F. Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta 1979, 575:185-192.
37. Askenase P.W. Immune inflammatory responses to parasites: the role of basophils, mast cells and vasoactive amines. Am J Trop Med Hyg 1977, 26:96-103.
38. Dvorak A.M. Basophil and mast cell degranulation and recovery. Blood Cell Biochemistry 1991, vol. 4:202-275. Plenum Press, New York.
39. Dvorak H.F., Dvorak A.M. Basophilic leukocytes: structure, function and role in disease. Clinics in Haematology 1975, vol. 4:651. Saunders WB Co, London.
40. Peters S.P., Kagey-Sobotka A., MacGlashan D.W., Siegel M.I., Lichtenstein L.M. The modulation of human basophil histamine release by products of the 5-lipoxygenase pathway. J Immunol 1982, 129:797-803.
41. Marone G., Giugliano R., Lembo G., Ayala F. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J Invest Dermatol 1986, 87:19-23.
42. Lawrence I.D., Warner J.A., Johan V.L., Hubbard W.C., Kagey-Sobotka A., Lichtenstein L.M. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. J Immunol 1987, 139:3062-3069.
43. Metcalfe D.D., Bland C.E., Wasserman S.I. Biochemical and functional characterization of proteoglycans isolated from basophils of patients with chronic myelogenous leukaemia. J Immunol 1984, 132:1943-1950.
44. Stevens R.L., Fox C.C., Lichtenstein L.M., Austen K.F. Identification of chondroitin sulphate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Proc Natl Acad Sci USA 1988, 85:2284-2287.
45. Gomori G. Chloroacyl esters as histochemical substrates. J Histochem Cytochem 1953, 1:469-470.
46. Benditt E.P. An enzyme in mast cells with some properties resembling chymotrypsin. Fed Proc 1956, 15:507.
47. Benditt E.P., Arase M. An enzyme in mast cells with properties like chymotrypsin. J Exp Med 1959, 110:451-460.
48. Glenner G.G., Cohen L.A. Histochemical demonstration of a species-specific trypsin-like enzyme in mast cells. Nature 1960, 185:846-847.
49. Schwartz L.B., Lewis R.A., Austen K.F. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem 1981, 256:11939-11943.
50. Schechter N.M., Choi J.K., Slavin D.A., Deresienski D.T., Sayama S., Dong G., et al. Identification of a chymotrypsin-like proteinase in human mast cells. J Immunol 1986, 137:962-970.
51. Castells M.C., Irani A.M., Schwartz L.B. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 1987, 138:2184-2189.
52. Irani A.M., Schechter N.M., Craig S.S., De Blois G., Schwartz L.B. Two types of human mast cells that have distinct neutral protease composition. Proc Natl Acad Sci USA 1986, 83:4464-4468.
53. Irani A.M., Schwartz L.B. Human mast cell heterogeneity. Allergy Proc 1994, 15:303-308.
54. Li L., Li Y., Reddel S.W., Cherrian M., Friend D.S., Stevens R.L., et al. Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy and drug-reactive patients. J Immunol 1998, 161:5079-5086.
55. Mochizuki A., McEuen A.R., Buckley M.G., Walls A.F. The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation. J Allergy Clin Immunol 2003, 112:102-108.
56. Burd P.R., Rogers H.W., Gordon J.R., Martin C.A., Jayaraman S., Wilson S.D., et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989, 170:245-257.
57. Plaut M., Pierce J.H., Watson C.J., Hanley-Hyde J., Nordan R.P., Paul W.E. Mast cell lines produce lymphokines in response to cross-linkage of Fce{open}RI or to calcium ionophores. Nature 1989, 339:64-67.
58. Wodnar-Filipowicz A., Heusser C.H., Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989, 339:150-152.
59. Gordon J.R., Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachetin. Nature 1990, 346:274-276.
60. Malaviya R., Ikeda T., Ross E., Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996, 381:77-80.
61. Echternacher B., Männel D.N., Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75-77.
62. Kitamura Y., Shimada M., Hatanaka K., Miyano Y. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 1977, 268:442-443.
63. Nocka K., Majumder S., Chabot B., Ray P., Cervone M., Bernstein A., et al. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - evidence for an impaired c-kit kinase in mutant mice. Gen Dev 1989, 3:816-826.
64. Nocka K., Buck J., Levi E., Besmer P. Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J 1990, 9:3287-3294.
65. Zsebo K.M., Williams D.A., Geissler E.N., Broudy V.C., Martin F.H., Atkins H.L., et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990, 63:213-224.
66. Tsai M., Shih L.S., Newlands G.F., Takeishi T., Langley K.E., Zsebo K.M., et al. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 1991, 174:125-131.
67. Kitamura Y., Kasugai T., Arizono N., Matsuda H Development of mast cells and basophils: processes and regulation mechanisms. Am J Med Sci 1993, 306:185-191.
68. Dvorak A.M., Seder R.A., Paul W.E., Morgan E.S., Galli S.J. Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro. Am J Pathol 1994, 144:160-170.
69. Valent P. Cytokines involved in growth and differentiation of human basophils and mast cells. Exp Dermatol 1995, 4:255-259.
70. De Barros C.M., Andrade L.R., Allodi S., Viskov C., Mourier P.A., Cavalcante M.C.M., et al. The hemolymph of the ascidian Styela plicata (Chordata-Tunicata) contains heparin inside basophil-like cells and a unique sulfated galactoglucan in the plasma. J Biol Chem 2007, 282:1615-1626.
71. Cavalcante M.C.M., Mourãom P.A., Pavão M.S. Isolation and characterization of a highly sulfated heparin sulfate from ascidian test cells. Biochim Biophys Acta 1999, 1428:77-87.
72. Cavalcante M.C.M., De Andrade L.R., Du Bocage Santos-Pinto C., Straus A.H., Takahashi H.K., Allodi S., et al. Colocalization of heparin and histamine in the intracellular granules of test cells from the invertebrate Styela plicata (chordata-tunicata). J Struct Biol 2002, 137:313-321.
73. Cavalcante M.C.M., Allodi S., Valente A.P., Straus A.H., Takahashi H.K., Mourão P.A.S., et al. Occurrence of heparin in the invertebrate Styela plicata (Tunicata) is restricted to cell layers facing the outside environment. J Biol Chem 2000, 275:36189-36196.
74. Wedemeyer J., Galli J.G. Mast cells and basophils in acquired immunity. Br Med Bull 2000, 56:936-955.
75. Arinobu Y., Iwasaki H., Gurish M.F., Mizuno S., Shigematsu H., Ozawa H., et al. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 2005, 102:18105-18110.
76. H3 region of IgE. J Immunol 1998, 161:5647-5655.
77. H3 region of IgE. J Immunol 2000, 164:589-595.
78. Gibbs B.F. Human basophils as effectors and immunomodulators of allergic inflammation and innate immunity. Clin Exp Med 2005, 5:43-49.
79. Gribaldeston M.A., Metz M., Yu M., Tsai M., Galli S.J. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol 2006, 18:751-760.
80. Dvorak A.M. Mast cell-derived mediators of enhanced microvascular permeability, vascular permeability factor/vascular endothelial growth factor, histamine, and serotonin, cause leakage of macromolecules through a new endothelial cell permeability organelle, the vesiculo-vacuolar organelle. Chem Immunol Allergy 2005, 85:185-204.
81. de Paulis A., Prevete N., Rossi F.W., Staibano S., Montuori N., Ragno P., et al. Expression and functions of vascular endothelial growth factors and their receptors in human basophils. J Immunol 2006, 177:7322-7331.
82. + T lymphocytes. Eur J Immunol 1996, 26:2517-2528.
83. + T cell effector functions. Immunity 2009, 31:665-676.
84. Kambayashi T., Allenspach E.J., Chang J.T., Zou T., Shoag J.E., Reiner S.L., et al. Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J Immunol 2009, 182:4686-4695.
85. Nakano N., Nishiyama C., Yagita H., Koyanagi A., Akiba H., Ohiba S., et al. Notch signaling confers antigen-presenting cell functions on mast cells. J Allergy Clin Immunol 2009, 123:74-81.
86. Gaudenzio N., Espagnolle N., Mars L.T., Liblau R., Valitutti S., Espinosa E. Cell-cell cooperation at the T helper cell/mast cell immunological synapse. Blood 2009, 114:4979-4988.
87. Gong J., Yang N.S., Croft M., Weng I.C., Sun L., Liu F.T., et al. The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface Fce{open}RI and MHC II. BMC Immunol 2010, 11:34.
88. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 2006, 176:2238-2248.
89. Hershko A.Y., Rivera J. Mast cell and T cell communication; amplification and control of adaptive immunity. Immunol Lett 2010, 128:98-104.
90. Sokol C.L., Chu N.Q., Yu S., Nish S.A., Laufer T.M., Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009, 10:713-720.
91. H2 cytokine-dependent immunity. Nat Immunol 2009, 10:697-705.
92. + T cells. Nat Immunol 2009, 10:706-712.
93. Sokol C.L., Barton G.M., Farr A.G., Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008, 9:310-318.
94. Féger F., Varadaradjalou S., Gao Z., Abraham S.N., Arock M. The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol 2002, 23:151-158.
95. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., et al. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006, 313:526-530.
96. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6:135-142.
97. + regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008, 29:771-781.
98. Piconese S., Gri G., Tripodo C., Musio S., Gorzanelli A., Frossi B., et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 2009, 114:2639-2648.
99. Merluzzi S., Frossi B., Gri G., Parusso S., Tripodo C., Pucillo C. Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells. Blood 2010, 115:2810-2817.
100. de Vries V.C., Elgueta R., Lee D.M., Noelle R.J. Mast cell protease 6 is required for allograft tolerance. Transplant Proc 2010, 42:2759-2762.
101. de Vries V.C., Noelle R.J. Mast cell mediators in tolerance. Curr Opin Immunol 2010, 22:643-648.
102. Wada T., Ishiwata K., Koseki H., Ishikura T., Ugajin T., Ohnuma N. Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. J Clin Invest 2010, 120:2867-2875.
103. Karasuyama H, Obata K, Wada T, Tsujimura Y, Mukai K. Newly appreciated roles for basophils in allergy and protective immunity. Allergy. doi:10.1111/j.1398-9995.2011.02613.x.
104. Denzel A., Maus U.A., Rodriguez Gomez M., Moll C., Niedermeier M., Winter C., et al. Basophils enhance immunological memory responses. Nat Immunol 2008, 9:733-742.
105. Rodriguez Gomez M., Talke Y., Goebel N., Hermann F., Reich B., Mack M. Basophils support the survival of plasma cells in mice. J Immunol 2010, 185:7180-7185.
106. Charles N., Watford W.T., Ramos H.L., Hellman L., Oettgen H.C., Gomez G. Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity 2009, 30:533-543.
107. Charles N., Hardwick D., Daugas E., Illei G.G., Rivera J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 2010, 16:701-707.